Skip to content

Spontaneous hepatitis C virus clearance occurs in up to 42% recently infected, HIV-negative IDUs

Does long-term HAART lead to a resurgence in immune activation and fall in CD4 count?

Microbicide Development Programme drops Emmelle for PRO 2000

Rare sexually transmitted infection seen in a cluster of HIV-positive men

Abacavir/3TC once daily pill gets scientific approval as Kivexa in Europe

Higher immune system activation prior to seroconversion leads to faster CD4 T-cell loss

HIV treatment proving effective for children in Côte d'Ivoire

South Africa slow to meet ARV targets, says new treatment watchdog

Initial NNRTI-based HAART regimens are sustained longer than PI-based HAART, Canadian study shows